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In Brief
 
Releasing Anchors
 
The degradation of extracellular ma-
trix by membrane-type 1 matrix me-
talloproteinase (MT1-MMP) clears
the way for invasive cancer cells, al-
lowing them to migrate. But, on page
893, Kajita et al. propose that MT1-
MMP has another function in getting
cells moving: it may cleave anchoring
proteins that would otherwise hold
the cell in place.
Kajita et al. look in particular at
CD44, an abundant cell–cell and cell–
matrix adhesion molecule. CD44 pro-
motes migration, presumably via
binding to extracellular molecules
such as hyaluronic acid (HA), which
activates intracellular signaling. But
CD44 binding to HA might also be
expected to physically retard the cell.
This is apparently where MT1-
MMP comes in. Kajita et al. find that
cotransfection of CD44 and MT1-
MMP stimulates motility. The motil-
ity of these transfected cells and of a
pancreatic tumor cell line is inhibited
by both MMP inhibitors and a domi-
nant-negative CD44 mutant that lacks
MMP cleavage sites. In the latter ex-
periment, the cells that do not receive
the mutant construct are motile and
shed soluble CD44, and yet the sur-
rounding transfected cells are not mo-
tile. This suggests that the important
event is the processing itself, rather
than the binding of the product of
 
processing. Kajita et al. therefore sug-
gest that the cleavage of CD44 by
MT1-MMP allows cells to detach once
CD44 has provided its positive signal.
 
Breaking into the Brain
 
Immune cells seeking to enter the
brain encounter two basement-mem-
brane obstacles—the endothelial and
parenchymal basement membranes.
On page 933, Sixt et al. describe some
of the extracellular matrix molecules
that make these layers distinct, and
suggest a model for the multi-step en-
try of cells into the brain.
Sixt et al. induce brain inflamma-
tion by immunizing with myelin. Dur-
ing the resultant experimental au-
toimmune encephalomyelitis (EAE, a
model for multiple sclerosis), some of
the invading cells get stuck between
the two layers. This allows Sixt et al.
to differentiate between the inner pa-
renchymal layer, containing laminins
1 and 2, and the outer endothelial
layer, containing laminins 8 and 10.
Laminin 10 is noticeably absent from
areas of infiltration.
In vitro adhesion assays demon-
strate that activated T cells adhere far
more strongly to laminin 10 than 8,
and not at all to laminins 1 and 2. Sixt
et al. suggest that high affinity of infil-
trating leukocytes for laminin 10 may
prevent migration, whereas three fac-
tors (increased turnover of laminin 8
in the endothelial cell basement mem-
brane, a decrease in the amount of
laminin 8 ligand on the endothelial
 
cell surface, plus low affinity adhesion
of infiltrating leukocytes for laminin
8) may increase penetrability of the
endothelial monolayer in areas lack-
ing laminin 10. Previous work is also
consistent with laminin 8 providing a
direct pro-migratory signal to attract
cells.
Work by others has shown that
metalloproteinases are necessary only
for the second step, in which invading
cells break through the remaining
barrier of the parenchymal basement
membrane. The metalloproteinases
may degrade obstructing matrix, lib-
erate adhesion molecules or chemoat-
tractants, or both.
 
Feedback on Stress
 
Many different stresses cause cells to
reduce translation rates drastically by
phosphorylating the alpha subunit of
translation initiation factor-2 (eIF2
 
 
 
).
On page 1011, Novoa et al. report that
the stress-induced protein GADD34
is a feedback inhibitor of this re-
sponse, allowing cells to recover from
the stress-induced shutdown.
Novoa et al. isolate the COOH ter-
minus of GADD34 in a screen for pro-
teins that prevent accumulation of a
stress-induced transcript. Lysates from
cells overproducing GADD34 have
increased dephosphorylating activity
specifically against eIF2
 
 
 
, and this ac-
tivity remains in GADD34 immuno-
precipitates. This suggests a parallel
with the 
 
 
 
1
 
34.5 protein from herpes
simplex virus (HSV), which was pre-
viously noted by Bernard Roizman
and co-workers to share a region of
similarity with GADD34 and to bind
the catalytic subunit of protein phos-
phatase 1 (PP1c). Indeed, GADD34
mutants that do not bind PP1c no 
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longer shut down the stress response.
Novoa et al. now want to test whether
GADD34 is, as they suspect, neces-
sary for attenuation of the stress re-
sponse in normal cells.
 
Proteasome Action, Post-ER
 
For secreted or plasma membrane
proteins, most quality control comes at
the level of the endoplasmic reticulum
(ER). On page 957, however, Ben-
harouga et al. report that COOH-ter-
minal truncations of the cystic fibrosis
transmembrane conductance regula-
tor (CFTR) are degraded largely after
the ER in a process that is initiated by
proteasomes, not lysosomes.
Wild-type CFTR is a complex, mul-
tidomain protein, 70% of which never
gets past the proteasome-dependent
degradation pathway at the level of
the ER. But the T70 truncation stud-
ied by Benharouga et al. is also unsta-
 
ble after it passes through the ER
quality-control apparatus. Delivery
from the Golgi to the plasma mem-
brane is normal, and inhibition of ly-
sosomal proteases does not prevent
continued degradation of T70. Protea-
some inhibitors do, however, increase
the survival time of surface-biotinyl-
ated T70.
Lysosomal protease inhibitors
cause the accumulation of protein
fragments, suggesting that initial pro-
teasome-dependent fragmentation is
followed by more complete degrada-
tion of these fragments in lysosomes.
T70 may be susceptible to protea-
some degradation because of its re-
duced stability, which Benharouga et
al. detect as an increase in protease
sensitivity in vitro, and a temperature
dependence of protein instability.
 
Signaling Not Sticking for 
Tumor Suppression
 
As a tumor suppressor, the cell–cell ad-
hesion protein E-cadherin could work
one of two ways. Earlier work suggested
that increased adhesion can inhibit cell
movement, and thus metastasis. But, on
page 1049, Gottardi et al. show that, at
least in their colorectal carcinoma cell
line, cadherin expression also results in
a direct suppression of proliferation,
via E-cadherin’s binding of the signal-
ing protein 
 
 
 
-catenin.
Gottardi et al. find that E-cad-
herin–mediated inhibition of anchor-
age-independent growth can be
achieved with a construct that lacks
adhesive properties (due to a foreign
extracellular domain) but retains the
ability to bind 
 
 
 
-catenin. Growth inhi-
bition can be reversed by adding an
activated version of 
 
 
 
-catenin’s tar-
get (the transcription factor TCF), or
by deleting the 
 
 
 
-catenin–binding do-
main in E-cadherin.
Despite this evidence for its mecha-
nism of action, E-cadherin does not
appear to be sequestering the majority
of 
 
 
 
-catenin. Instead, Gottardi et al.
report that E-cadherin binds only the
subset of 
 
 
 
-catenin that is capable of
binding to TCF. Future work will focus
on identifying what distinguishes this
pool of 
 
 
 
-catenin and on determining
whether the adhesion-promoting activ-
ity of E-cadherin is more important
later in cancer progression, when tu-
mors become invasive.
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